Literature DB >> 1989911

Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia.

J V Brown1, W A Peters, D J Corwin.   

Abstract

A retrospective review of 578 patients with invasive cervical cancer identified 8 patients with a history of one or more cone biopsies for treatment of cervical intraepithelial neoplasia. The cone biopsy and hysterectomy specimens were reviewed to identify factors predictive of the subsequent development of invasive cancer. The mean interval from cone biopsy to diagnosis of invasive carcinoma was 6.7 years (range 1.5-16.5 years). High-grade intraepithelial neoplasia is a potentially invasive lesion. Adenocarcinoma in situ was identified as a high-risk lesion that may be inadequately treated by cone biopsy. Four patients developed invasive squamous cancer in spite of complete excision of the initial lesion. Patients who have high-grade intraepithelial neoplasia treated with cone biopsy require long-term follow-up, and conization may hamper the subsequent diagnosis of preinvasive lesions.

Entities:  

Mesh:

Year:  1991        PMID: 1989911     DOI: 10.1016/0090-8258(91)90079-k

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Clinical significance of atypical squamous cells of undetermined significance after treatment for cervical intraepithelial grade 3 neoplasia: A retrospective single-center cohort study.

Authors:  Toshimichi Onuma; Kimihisa Tajima; Kumiko Sato; Katsushige Hattori; Shin Fukuda; Takahiro Tsuji; Yoshio Yoshida
Journal:  Mol Clin Oncol       Date:  2017-10-04

2.  Risk Factors for Residual Disease in Hysterectomy Specimens After Conization in Post-Menopausal Patients with Cervical Intraepithelial Neoplasia Grade 3.

Authors:  Xiaoqi Sun; Huifang Lei; Xiaoyan Xie; Guanyu Ruan; Jian An; Pengming Sun
Journal:  Int J Gen Med       Date:  2020-11-10

3.  Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.

Authors:  S V Polacarz; J Darne; E G Sheridan; R Ginsberg; F Sharp
Journal:  J Clin Pathol       Date:  1991-11       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.